Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2012
11/15/2012US20120288895 Compositions and Methods for Modulating Hemostasis Using Variant Forms of Activated Factor V
11/15/2012US20120288894 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity
11/15/2012US20120288893 Seed-specific expression vector and its construction methods and applications
11/15/2012US20120288892 Methods for Producing Polypeptidies in Protease-Deficient Mutants of Trichoderma
11/15/2012US20120288882 Type iv secretion system proteins in sero-detection of anaplasma phagocytophilum
11/15/2012US20120288564 Interpenetrating polymer network comprising fibrin
11/15/2012US20120288526 Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods
11/15/2012US20120288502 Compositions and methods for improving potency and breadth of hiv antibodies
11/15/2012US20120288477 Type of consensus interferon and preparation method thereof
11/15/2012CA2835630A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012CA2835603A1 Antibody capable of specifically recognizing transferrin receptor
11/15/2012CA2835506A1 Monoclonal antibody for acetylamantadine
11/14/2012EP2522727A1 Highly functional bispecific antibody
11/14/2012EP2522358A1 Peptides against rotavirus infection
11/14/2012EP2521787A2 Enhanced protein expression
11/14/2012EP2521704A1 Process for the specific isotopic labeling of methyl groups of val, leu and ile
11/14/2012EP1707627B1 Antagonistic anti-CD40 antibody mutant
11/14/2012CN1890367B Surfactant-tolerant cellulase and method of converting the same
11/14/2012CN102782149A Engineered anti-TSLP antibody
11/14/2012CN102782148A Antikine antibodies that bind to multiple CC chemokines
11/14/2012CN102782132A Orthogonal Q-ribosomes
11/14/2012CN102782131A Modified antibody composition
11/14/2012CN102782130A High-expression promoter derived from kluyveromyces marxianus
11/14/2012CN102782125A Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof
11/14/2012CN102781964A Anti-CDH3 antibodies and uses thereof
11/14/2012CN102778565A Rapid 1-type dengue gold-marking diagnosis test paper strip
11/14/2012CN102776262A Preparation method of high-F-value tuna oligopeptide
11/14/2012CN102776261A Process for preparing human G-CSF
11/14/2012CN102776260A Method for effectively expressing recombinant human coagulation factor VIII
11/14/2012CN102776259A Preparation method of long insulin-like growth factor 1 mutant
11/14/2012CN102776258A Fermentation method for coproduction of S-adenosyl-L-methionine and glutathione
11/14/2012CN102776218A Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/14/2012CN102776147A Gene-recombined peoriae paenibacillus, and construction method and application thereof
11/14/2012CN102190732B PGBD-2 fusion defensin, and preparation method and application thereof
11/14/2012CN102121029B Plant expression vector and construction method thereof, and method for producing chicken alpha interferon by utilizing crowtoe as bioreactor
11/14/2012CN101748179B Preparation method of feather protein peptide
11/14/2012CN101747416B B-cell antigenic multi-epitope peptide linked in tandem in OmpU of vibrio mimicus, making method and application thereof
11/14/2012CN101679518B The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
11/14/2012CN101608206B Method for preparing soy protein immune-active peptides and product thereof
11/14/2012CN101402921B Method for producing gamma-glutamylcycteine
11/13/2012US8309795 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
11/13/2012US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/13/2012US8309688 Monkey homolog of human oncostatin M and methods of use thereof
11/13/2012US8309686 Neurotoxins with enhanced target specificity
11/13/2012US8309328 Compositions and methods for production of fermentable sugars
11/13/2012US8309327 Method of producing an immunogenic composition
11/13/2012US8309326 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
11/13/2012US8309325 Efficient production of heterologous proteins using mannosyl transferase inhibitors
11/13/2012US8309324 Promoters and proteins from Clostridium thermocellum and uses thereof
11/13/2012US8309315 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
11/13/2012US8309102 Methods and compositions for immunizing against Chlamydia infection
11/13/2012US8309100 Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012CA2641565C Nel-related proteins type 1 and 2, and polynucleotides encoding them
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/13/2012CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies
11/13/2012CA2413576C Streptococcus pyogenes antigens
11/13/2012CA2397675C Altered strain of the modified vaccinia virus ankara (mva)
11/13/2012CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
11/08/2012WO2012151481A1 Compositions for inhibiting masp-2 dependent complement acitivation
11/08/2012WO2012150421A1 Method for obtaining an alfalfa protein extract and reusable co-products
11/08/2012WO2012103260A3 High-throughput methods to produce, validate and characterize mmabs
11/08/2012US20120284871 Protein expression systems
11/08/2012US20120284810 Anti-cd151 antibodies and their use in the treatment of cancer
11/08/2012US20120283420 Production of Multi-Antennary N-Glycan Structures in Plants
11/08/2012US20120283414 Monoclonal Antibodies for Ebola and Marburg Viruses
11/08/2012US20120283412 Orphan nuclear receptor
11/08/2012US20120283408 Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein
11/08/2012US20120283318 Replicating viral vectors for gene therapy
11/08/2012US20120283314 Sodium channel protein type iii alpha-subunit splice variant
11/08/2012US20120282689 Expanding the Eukaryotic Genetic Code
11/08/2012US20120282654 Antibody purification
11/08/2012US20120282653 Method for making polypeptides
11/08/2012US20120282652 Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties
11/08/2012US20120282624 Integration of genes into the chromosome of saccharopolyspora spinosa
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282289 Staphylococcal antigens
11/08/2012US20120282287 Novel Flavivirus Antigens
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
11/08/2012US20120282268 Novel Cell Wall Components of Enterococci and Uses Thereof
11/08/2012US20120282263 Compositions for inhibiting masp-2 dependent complement activation
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282253 Interleukin-10 antibodies
11/08/2012US20120282246 Compositions and methods for antibody and ligand identification
11/08/2012US20120282231 Human lysosomal proteins from plant cell culture
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2832871A1 Compositions for inhibiting masp-2 dependent complement activation
11/07/2012EP2520648A1 Anti-iga1 antibody
11/07/2012EP2520589A1 Anti-cd27 antibody
11/07/2012EP2520586A1 Method of producing factor VIII proteins by recombinant methods
11/07/2012EP2520310A1 Cellular permissivity factor for viruses, and uses thereof
11/07/2012EP2519542A1 Anti-cdh3 antibodies and uses thereof
11/07/2012CN102770555A Improved bacterial membrane protein secrection
11/07/2012CN102770554A Antibody glycosylation variants
11/07/2012CN102770529A Human monoclonal antibodies to human nucleolin
11/07/2012CN102770448A Compositions and methods for the detection of antibodies to native human leukocyte antigen
11/07/2012CN102766671A Method for extracting proteins from vitamin C fermented mash
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 1125